Infectious Disease
Pneumonitis
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
Pneumonitis is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
5
clinical trials
Completed4 · 80%
Suspended1 · 20%
Clinical Trials
Trial Activity
Rituximab in Interstitial Pneumonitis
Completed·—·Phase 2/3·NCT02251964·20 enrolled
Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1
Completed·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·N/A·NCT07036016·67,818 enrolled
Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis
Suspended·National Institute for Tuberculosis and Lung Diseases, Poland·Phase 4·NCT04036721·85 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)